Post featured image

GoWellMag

Nutrigenetics in Preventive Medicine: The Real Personalized Diet

The concept of a “personalized diet” has traditionally been associated with questionnaires, food preferences, or caloric adjustments based on clinical history, body composition, or physical activity levels. However, within the current framework of preventive medicine, personalization requires a deeper understanding of the biological mechanisms that determine how each individual metabolically responds to food.

In this context, nutrigenetics emerges as a key tool within precision nutrition. Genetic information enables the stratification of biological predispositions and helps prioritize interventions before clinical alterations appear, transforming prevention into a measurable and targeted strategy.

Nutrition has always been a preventive tool. Genetic information, however, allows clinicians to move a step further. Not all patients share the same degree of vulnerability. Nutrigenetics helps identify which metabolic pathways carry higher susceptibility and, therefore, where intervention and monitoring should be intensified.

Managing hypertension in a genetically protective profile is not the same as in a patient with a higher atherogenic burden and variants associated with reduced folate metabolism efficiency, such as certain MTHFR polymorphisms linked to hyperhomocysteinemia. In the latter case, beyond weight management and dietary patterns, closer monitoring of lipid profiles, homocysteine, and folate status becomes essential.

The difference lies in the underlying biological susceptibility. That is where prevention becomes precision.

If genetic information allows the shift from general prevention to individual stratification, the next question is: which metabolic domains deserve particular attention?

In clinical practice, the integration of nutrigenetics and preventive medicine can be structured around four interrelated domains that influence long-term health risk.

1. Lipid metabolism and cardiovascular risk
A large portion of silent cardiometabolic risk develops within this domain. Genetic variability influences lipoprotein processing, qualitative response to different types of fats, and susceptibility to atherogenic profiles. Stratifying this predisposition allows clinicians to calibrate the intensity of both intervention and monitoring.

2. Glycemic profile and insulin resistance
Glucose regulation is another central pillar of prevention. Individual responses to carbohydrates and susceptibility to insulin dysfunction vary significantly. Understanding this predisposition helps define the quality, timing, and quantity of carbohydrate intake more precisely, as well as determining when to intensify metabolic monitoring, particularly in contexts such as overweight, menopause, or family history of type 2 diabetes.

3. Digestive tract and food intolerances
Digestive symptoms often influence adherence, wellbeing, and the effectiveness of nutritional interventions. Integrating genetic predispositions related to intolerances or celiac disease provides a structured framework to contrast with clinical history and determine when additional testing is appropriate. This approach helps avoid prolonged trial-and-error strategies commonly seen in patients with nonspecific digestive symptoms.

4. Folate metabolism and methylation
This domain becomes particularly relevant when considered within cardiovascular and inflammatory contexts. Certain variants, such as those affecting folate metabolism efficiency (for example, in the MTHFR gene), may increase susceptibility to hyperhomocysteinemia. In patients with elevated cardiovascular risk, this adds another layer of vulnerability that can influence preventive strategies.

Beyond blood pressure or lipid control, optimizing folate status and methylation cofactors becomes part of the intervention strategy. Evaluating this domain allows clinicians to contextualize laboratory findings and refine nutritional interventions with greater preventive precision.

Within this framework, platforms such as N-GENE have developed systems specifically designed for healthcare professionals. Through a single saliva sample and high-density genotyping processed in certified laboratories, clinicians gain access to a platform where results can be explored, reports downloaded, and genetic insights integrated into daily clinical practice.

One of the key advantages in preventive medicine is the stability of genetic data. A single sample allows the incorporation of future scientific updates without repeating the testing process, supporting long-term follow-up and the evolution of preventive care strategies.